CRSP vs NTLA
CRSP 与 NTLA 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | CRSPCRISPR THERAPEUTICS AG | NTLAINTELLIA THERAPEUTICS, INC. |
|---|---|---|
| 市值 | $5.01B | $1.59B |
| 市销率 | 1427.0x | 23.6x |
| 营收同比增长 | -90.6% | 16.9% |
| 净利同比增长 | -58.8% | 20.5% |
| 息税前利润率 | -18933.6% | -651.7% |
| 净资产收益率 | -33.3% | -56.7% |
| 投入资本回报率 | -32.6% | — |
| 一年总回报 | -10.5% | -1.6% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:CRSP vs NTLA
| 指标 | CRSP | NTLA |
|---|---|---|
| 期末价值 | $36.8K | $9.0K |
| 总回报 | +267.9% | -9.9% |
| 年化收益 (CAGR) | +14.1% | -1.1% |
| 波动率 | 64.0% | 78.6% |
| 夏普比率 | 0.46 | 0.33 |
| 索提诺比率 | 0.71 | 0.48 |
| 最大回撤 | -85.1% | -96.5% |
基于 2489 个共同交易日,2016-10-19 → 2026-09-15 · 无风险利率 4.11%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)